The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Bioprinting the Cancer Microenvironment
Open accessAbstract
Cancer is intrinsically complex, comprising both heterogeneous cellular compositions and microenvironmental cues. During the various stages of cancer initiation, development, and metastasis, cell-cell interactions (involving vascular and immune cells besides cancerous cells) as well as cell-extracellular matrix (ECM) interactions (e.g., alteration in stiffness and composition of the surrounding matrix) play major roles. Conventional cancer models both two- and three-dimensional (2D and 3D) present numerous limitations as they lack good vascularization and cannot mimic the complexity of tumors, thereby restricting their use as biomimetic models for applications such as drug screening and fundamental cancer biology studies. Bioprinting as an emerging biofabrication platform enables the creation of high-resolution 3D structures and has been extensively used in the past decade to model multiple organs and diseases. More recently, this versatile technique has further found its application in studying cancer genesis, growth, metastasis, and drug responses through creation of accurate models that recreate the complexity of the cancer microenvironment. In this review we will focus first on cancer biology and limitations with current cancer models. We then detail the current bioprinting strategies including the selection of bioinks for capturing the properties of the tumor matrices, after which we discuss bioprinting of vascular structures that are critical toward construction of complex 3D cancer organoids. We finally conclude with current literature on bioprinted cancer models and propose future perspectives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Hydrogels for biomedical applications
Hoffman, A. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00239-3 · Cited by 4,864
Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology
Peppas, N. A., Hilt, J. Z., Khademhosseini, A., & Langer, R. (2006) · Advanced Materials · doi:10.1002/adma.200501612 · Cited by 4,109
Self-citationMicroenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Hydrogels for biomedical applications
Hoffman, A. S. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.010 · Cited by 3,396
Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels
Yue, K., Trujillo-de Santiago, G., Alvarez, M. M., Tamayol, A., Annabi, N., & Khademhosseini, A. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.08.045 · Cited by 3,146
Self-citationExploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
Cited by
Bioinks for 3D bioprinting: an overview
Gungor-Ozkerim, P. S., Inci, I., Zhang, Y. S., Khademhosseini, A., & Dokmeci, M. R. (2018) · Biomaterials Science · doi:10.1039/c7bm00765e · Cited by 1,428
Self-citation3D bioprinting of tissues and organs for regenerative medicine
Vijayavenkataraman, S., Yan, W.-C., Lu, W. F., Wang, C.-H., & Fuh, J. Y. H. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.004 · Cited by 630
Current and emerging applications of 3D printing in medicine
Liaw, C.-Y., & Guvendiren, M. (2017) · Biofabrication · doi:10.1088/1758-5090/aa7279 · Cited by 604
3D Cell Culture Systems: Tumor Application, Advantages, and Disadvantages
Habanjar, O., Diab-Assaf, M., Caldefie-Chezet, F., & Delort, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212200 · Cited by 547
Extrusion Bioprinting of Shear‐Thinning Gelatin Methacryloyl Bioinks
Liu, W., Heinrich, M. A., Zhou, Y., Akpek, A., Hu, N., Liu, X., Guan, X., Zhong, Z., Jin, X., Khademhosseini, A., et al. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201601451 · Cited by 503
Self-citationRecent Advances in Bioink Design for 3D Bioprinting of Tissues and Organs
Ji, S., & Guvendiren, M. (2017) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2017.00023 · Cited by 490
Hoarau-Véchot, J., Rafii, A., Touboul, C., & Pasquier, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010181 · Cited by 489
Microfluidics‐Enabled Multimaterial Maskless Stereolithographic Bioprinting
Miri, A. K., Nieto, D., Iglesias, L., Goodarzi Hosseinabadi, H., Maharjan, S., Ruiz‐Esparza, G. U., Khoshakhlagh, P., Manbachi, A., Dokmeci, M. R., Chen, S., et al. (2018) · Advanced Materials · doi:10.1002/adma.201800242 · Cited by 431
Self-citationSpatiotemporal hydrogel biomaterials for regenerative medicine
Brown, T. E., & Anseth, K. S. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00445a · Cited by 428
Rapid Continuous Multimaterial Extrusion Bioprinting
Liu, W., Zhang, Y. S., Heinrich, M. A., De Ferrari, F., Jang, H. L., Bakht, S. M., Alvarez, M. M., Yang, J., Li, Y., Trujillo‐de Santiago, G., et al. (2017) · Advanced Materials · doi:10.1002/adma.201604630 · Cited by 424
Self-citationThe production of 3D tumor spheroids for cancer drug discovery
Sant, S., & Johnston, P. A. (2017) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2017.03.002 · Cited by 404
The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
Senthebane, D. A., Rowe, A., Thomford, N. E., Shipanga, H., Munro, D., Mazeedi, M. A. M. A., Almazyadi, H. A. M., Kallmeyer, K., Dandara, C., Pepper, M. S., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071586 · Cited by 399
Interplay between materials and microfluidics
Hou, X., Zhang, Y. S., Santiago, G. T.-D., Alvarez, M. M., Ribas, J., Jonas, S. J., Weiss, P. S., Andrews, A. M., Aizenberg, J., & Khademhosseini, A. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.16 · Cited by 387
Self-citationLi, Y.-C., Zhang, Y. S., Akpek, A., Shin, S. R., & Khademhosseini, A. (2016) · Biofabrication · doi:10.1088/1758-5090/9/1/012001 · Cited by 385
Self-citationBiałkowska, K., Komorowski, P., Bryszewska, M., & Miłowska, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176225 · Cited by 382
3D bioprinting for drug discovery and development in pharmaceutics
Peng, W., Datta, P., Ayan, B., Ozbolat, V., Sosnoski, D., & Ozbolat, I. T. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.05.025 · Cited by 313
Digitally Tunable Microfluidic Bioprinting of Multilayered Cannular Tissues
Pi, Q., Maharjan, S., Yan, X., Liu, X., Singh, B., van Genderen, A. M., Robledo‐Padilla, F., Parra‐Saldivar, R., Hu, N., Jia, W., et al. (2018) · Advanced Materials · doi:10.1002/adma.201706913 · Cited by 305
Self-citationEmerging Technologies in Multi‐Material Bioprinting
Ravanbakhsh, H., Karamzadeh, V., Bao, G., Mongeau, L., Juncker, D., & Zhang, Y. S. (2021) · Advanced Materials · doi:10.1002/adma.202104730 · Cited by 266
Self-citationModeling tumor phenotypes in vitro with three-dimensional bioprinting
Langer, E. M., Allen-Petersen, B. L., King, S. M., Kendsersky, N. D., Turnidge, M. A., Kuziel, G. M., Riggers, R., Samatham, R., Amery, T. S., Jacques, S. L., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.090 · Cited by 256
Organ-on-chip models of cancer metastasis for future personalized medicine: From chip to the patient
Caballero, D., Kaushik, S., Correlo, V. M., Oliveira, J. M., Reis, R. L., & Kundu, S. C. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.005 · Cited by 221
Handheld co-axial bioprinting: application to in situ surgical cartilage repair
Duchi, S., Onofrillo, C., O’Connell, C. D., Blanchard, R., Augustine, C., Quigley, A. F., Kapsa, R. M. I., Pivonka, P., Wallace, G., Di Bella, C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05699-x · Cited by 219
Tumour-on-a-chip: microfluidic models of tumour morphology, growth and microenvironment
Tsai, H.-F., Trubelja, A., Shen, A. Q., & Bao, G. (2017) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0137 · Cited by 214
The arrival of commercial bioprinters – Towards 3D bioprinting revolution!
Choudhury, D., Anand, S., & Naing, M. W. (2024) · International Journal of Bioprinting · doi:10.18063/ijb.v4i2.139 · Cited by 189
Trujillo-de Santiago, G., Flores-Garza, B. G., Tavares-Negrete, J. A., Lara-Mayorga, I. M., González-Gamboa, I., Zhang, Y. S., Rojas-Martínez, A., Ortiz-López, R., & Álvarez, M. M. (2019) · Materials · doi:10.3390/ma12182945 · Cited by 184
“approaches [210–212] will certainly simplify the fabrication of complex tumorous tissues [206,213].”
BackgroundSelf-citationEmerging tumor spheroids technologies for 3D in vitro cancer modeling
Rodrigues, T., Kundu, B., Silva-Correia, J., Kundu, S. C., Oliveira, J. M., Reis, R. L., & Correlo, V. M. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.018 · Cited by 178
3D Bioprinting of Breast Cancer Models for Drug Resistance Study
Wang, Y., Shi, W., Kuss, M., Mirza, S., Qi, D., Krasnoslobodtsev, A., Zeng, J., Band, H., Band, V., & Duan, B. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01277 · Cited by 157
Bioprinting technologies for disease modeling
Memic, A., Navaei, A., Mirani, B., Cordova, J. A. V., Aldhahri, M., Dolatshahi-Pirouz, A., Akbari, M., & Nikkhah, M. (2017) · Biotechnology Letters · doi:10.1007/s10529-017-2360-z · Cited by 73
Portable hand-held bioprinters promote in situ tissue regeneration
Pazhouhnia, Z., Beheshtizadeh, N., Namini, M. S., & Lotfibakhshaiesh, N. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10307 · Cited by 60
3D inkjet printing of biomaterials: Principles and applications
Barui, S. (2021) · MEDICAL DEVICES & SENSORS · doi:10.1002/mds3.10143 · Cited by 48
Avnet, S., Lemma, S., Cortini, M., Di Pompo, G., Perut, F., & Baldini, N. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00305 · Cited by 29
Bioengineered in vitro models of thrombosis: methods and techniques
Zhang, Y. S., Oklu, R., & Albadawi, H. (2017) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2017.08.08 · Cited by 23
Self-citation
Metadata
- Authors
- Zhang, Y. S., Duchamp, M., Oklu, R., Ellisen, L. W., Langer, R., & Khademhosseini, A.
- Venue
- ACS Biomaterials Science & Engineering
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-07-05
- Volume
- 2
- Issue
- 10
- Pages
- 1710-1721
- ISSN
- 2373-9878 (ISSN-L)
- OpenAlex
- W2435054323
- Cited by
- 248
- References
- 31
- FWCI
- 12.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.